Toru Yamaguchi
Overview
Explore the profile of Toru Yamaguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
2171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Demura S, Ohara T, Tauchi R, Takimura K, Watanabe K, Suzuki S, et al.
J Neurosurg Spine
. 2022 Dec;
38(2):192-198.
PMID: 36461844
Objective: Various complications have been reported in the treatment of pediatric spinal deformities. Among these, instrument-related complications could be critical concerns and risks of reoperation. This study aimed to identify...
12.
Tsuda S, Nagata J, Yamaguchi T, Cho T, Mori T, Yokota M, et al.
Tokai J Exp Clin Med
. 2022 Nov;
47(4):194-198.
PMID: 36420552
The patient was a 62-year-old woman. She had been treated for systemic lupus erythematosus (SLE) for 15 years and had a stable clinical course with cyclosporine, prednisolone, and ticlopidine. She...
13.
Nakamura T, Wada A, Yamaguchi R, Iwamoto M, Takamura K, Yanagida H, et al.
Clin Orthop Relat Res
. 2022 Nov;
481(4):808-819.
PMID: 36374570
Background: Legg-Calvé-Perthes disease (LCPD) is a childhood hip disease characterized by osteonecrosis of the femoral head. Because severe deformity of the femoral head can cause secondary osteoarthritis in adulthood, progressive...
14.
Kuribayashi R, Kasuga M, Kuwana K, Yamaguchi T
Ther Innov Regul Sci
. 2022 Sep;
57(2):173-177.
PMID: 36100793
The Ministry of Health, Labour and Welfare (MHLW) in Japan approved the first generic version of Nasonex in February 2018. The Pharmaceuticals and Medical Devices Agency requires in vitro, pharmacokinetic,...
15.
Kawaguchi K, Nakamura T, Wada A, Takamura K, Yanagida H, Yamaguchi T
J Orthop
. 2022 Mar;
31:6-12.
PMID: 35295706
Background: Pediatric acute osteomyelitis and septic arthritis can destroy growth plate cartilage and joint cartilage, causing permanent deformities and growth disorders. Preventing the contraction of osteoarticular infections is important. Various...
16.
Takashima K, Koga Y, Anzai T, Migita K, Yamaguchi T, Ishikawa A, et al.
Pharmaceuticals (Basel)
. 2022 Feb;
15(2).
PMID: 35215338
Photoimmunotherapy (PIT) is a promising tumor-selective treatment method that uses light-absorbing dye-conjugated antibodies and light irradiation. It has been reported that IR700 fluorescence changes with light irradiation. The purpose of...
17.
Yamaguchi R, Nakamura T, Yanagida H, Yamaguchi T, Takamura K, Wada A, et al.
J Pediatr Orthop
. 2022 Feb;
42(5):246-252.
PMID: 35180723
Background: Congenital diastasis of the pubic symphysis (CDPS) is a rare musculoskeletal malformation in the exstrophy-epispadias complex that is potentially associated with the development of hip dysplasia. The purpose of...
18.
Kasuga M, Kuribayashi R, Ogawa T, Ugi A, Yamaguchi T, Takagi K, et al.
Eur J Drug Metab Pharmacokinet
. 2021 Sep;
46(6):711-719.
PMID: 34586614
The growth of healthcare cost is a serious issue in many countries. Generic drug products play an essential role in reducing healthcare costs because they are less costly than the...
19.
Stewart N, Nakano H, Sugai S, Tomohiro M, Kase Y, Uchio Y, et al.
Chemphyschem
. 2021 May;
22(10):905.
PMID: 33998762
The front cover artwork is provided by the group of Dr. Neil J. Stewart, Prof. Hiroshi Hirata, and Dr. Shingo Matsumoto (Hokkaido University, Japan) as well as Dr. Takuya Hashimoto...
20.
Stewart N, Nakano H, Sugai S, Tomohiro M, Kase Y, Uchio Y, et al.
Chemphyschem
. 2021 Feb;
22(10):915-923.
PMID: 33590933
Hyperpolarized [1- C]fumarate is a promising magnetic resonance imaging (MRI) biomarker for cellular necrosis, which plays an important role in various disease and cancerous pathological processes. To demonstrate the feasibility...